These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 8722333)
21. Lymphocyte reconstitution following allogeneic hematopoietic stem cell transplantation: a retrospective study including 148 patients. Heining C; Spyridonidis A; Bernhardt E; Schulte-Mönting J; Behringer D; Grüllich C; Jakob A; Bertz H; Finke J Bone Marrow Transplant; 2007 May; 39(10):613-22. PubMed ID: 17384658 [TBL] [Abstract][Full Text] [Related]
22. [CD34+ cell dose and hematologic recovery in allogeneic peripheral blood stem cell transplantation]. Sawada H; Wake A; Yamasaki Y; Izumi Y Rinsho Ketsueki; 2000 Jun; 41(6):500-6. PubMed ID: 10921350 [TBL] [Abstract][Full Text] [Related]
23. Flow cytometric assessment of lymphocyte subsets, lymphoid progenitors, and hematopoietic stem cells in allogeneic stem cell grafts. Theilgaard-Mönch K; Raaschou-Jensen K; Palm H; Schjødt K; Heilmann C; Vindeløv L; Jacobsen N; Dickmeiss E Bone Marrow Transplant; 2001 Dec; 28(11):1073-82. PubMed ID: 11781619 [TBL] [Abstract][Full Text] [Related]
24. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies. Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687 [TBL] [Abstract][Full Text] [Related]
25. [Clinical application of allogeneic peripheral blood stem cell transplantation]. Harada M; Ideguchi S Rinsho Ketsueki; 1996 Jul; 37(7):598-603. PubMed ID: 8779779 [No Abstract] [Full Text] [Related]
26. Treatment of relapse after allogeneic bone marrow transplantation with unmanipulated G-CSF-mobilized peripheral blood stem cell preparation. Siegert W; Beyer J; Kingreen D; Blasczyk R; Baurmann H; Schwella N; Schleicher J; Kirsch A; Huhn D Bone Marrow Transplant; 1998 Sep; 22(6):579-83. PubMed ID: 9758347 [TBL] [Abstract][Full Text] [Related]
27. Recombinant human granulocyte colony-stimulating factor (rh-G-CSF) may accelerate hematopoietic recovery after HLA-identical sibling allogeneic peripheral blood stem cell transplantation. Ozcan M; Ustün C; Akçağlayan E; Akan H; Arslan O; Ilhan O; Beksaç M; Gürman G; Demirer T; Arat M; Celebi H; Konuk N; Uysal A; Koç H Bone Marrow Transplant; 2001 Mar; 27(5):499-505. PubMed ID: 11313683 [TBL] [Abstract][Full Text] [Related]
28. GM-CSF-based mobilization effect in normal healthy donors for allogeneic peripheral blood stem cell transplantation. Sohn SK; Kim JG; Seo KW; Chae YS; Jung JT; Suh JS; Lee KB Bone Marrow Transplant; 2002 Jul; 30(2):81-6. PubMed ID: 12132046 [TBL] [Abstract][Full Text] [Related]
29. A pilot study of cytoreductive chemotherapy combined with infusion of additional peripheral blood stem cells reserved at time of harvest for transplantation in case of relapsed hematologic malignancies after allogeneic peripheral blood stem cell transplant. Kim JG; Sohn SK; Kim DH; Lee NY; Suh JS; Lee KS; Lee KB Bone Marrow Transplant; 2004 Jan; 33(2):231-6. PubMed ID: 14647258 [TBL] [Abstract][Full Text] [Related]
30. Isolation of purified autologous peripheral blood CD34+ cells with low T cell content using CliniMACS device--a local experience. Leong CF; Habsah A; Teh HS; Goh KY; Fadilah SA; Cheong SK Malays J Pathol; 2008 Jun; 30(1):31-6. PubMed ID: 19108409 [TBL] [Abstract][Full Text] [Related]
31. [Current status of allogeneic-peripheral blood stem cell transplantation and the possibility for unrelated donor-peripheral blood stem cell transplantation]. Shinagawa K; Harada M Rinsho Ketsueki; 1998 May; 39(5):342-4. PubMed ID: 9637881 [No Abstract] [Full Text] [Related]
32. Individually adjusted prophylactic donor lymphocyte infusions after CD34-selected allogeneic peripheral blood stem cell transplantation. Ferrá C; Rodríguez-Luaces M; Gallardo D; Encuentra M; Martín-Henao GA; Peris J; Ancín I; Sarrá J; Berlanga JJ; García J; Grañena A Bone Marrow Transplant; 2001 Nov; 28(10):963-8. PubMed ID: 11753552 [TBL] [Abstract][Full Text] [Related]
33. [Allogeneic peripheral blood stem cell transplantation in 30 patients with hematologic disorders]. Sawada H; Morimoto H; Wake A; Yamasaki Y; Izumi Y; Kuroiwa M; Osabe S; Imamura Y; Egami K; Tsukamoto A; Sanada I; Kiyokawa T; Kawano F Rinsho Ketsueki; 1998 Nov; 39(11):1085-91. PubMed ID: 9866419 [TBL] [Abstract][Full Text] [Related]
34. High frequency of donor chimerism after allogeneic transplantation of CD34+-selected peripheral blood cells. Briones J; Urbano-Ispizua A; Lawler M; Rozman C; Gardiner N; Marín P; Salgado C; Féliz P; McCann S; Montserrat E Exp Hematol; 1998 May; 26(5):415-20. PubMed ID: 9590658 [TBL] [Abstract][Full Text] [Related]
35. A pilot study of allogeneic bone marrow transplantation using related donors stimulated with G-CSF. Isola LM; Scigliano E; Skerrett D; Shank B; Ross V; Najfeld V; Fruchtman S Bone Marrow Transplant; 1997 Dec; 20(12):1033-7. PubMed ID: 9466275 [TBL] [Abstract][Full Text] [Related]
36. Etoposide 1.0 g/m2 or 1.5 g/m2 combined with granulocyte colony-stimulating factor for mobilization of peripheral blood stem cells in patients with malignancy: efficacy and toxicity. Li B; Yang JL; Shi YK; He XH; Han XH; Zhou SY; Liu P; Yang S; Zhang CG Cytotherapy; 2009; 11(3):362-71. PubMed ID: 19037766 [TBL] [Abstract][Full Text] [Related]
37. Relationship of CD34+ cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantation. Kiss JE; Rybka WB; Winkelstein A; deMagalhaes-Silverman M; Lister J; D'Andrea P; Ball ED Bone Marrow Transplant; 1997 Feb; 19(4):303-10. PubMed ID: 9051238 [TBL] [Abstract][Full Text] [Related]